Hydration Pharmaceuticals (ASX:HPC) received firm commitments to raise AU$650,000 through the issue of 65 million shares at AU$0.01 apiece, according to a Tuesday filing with the Australian bourse.
A total of 60 million shares will be allocated to Joseph Constable, who will also join the board as a non-executive director after the placement's completion, the filing said. The remaining shares will be allocated to another investor.
The company also plans to raise an additional AU$610,000 through a pro rata entitlement offer, offering one new share for every five existing shares held to eligible shareholders.
Funds will be used to maintain sales momentum in US operations, per the filing.
Shares fell 10% in midday trade Wednesday.
Price (AUD): $0.01, Change: $-0.0010, Percent Change: -10.00%
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。